(Reuters) - Cipla Ltd, India's second largest drugmaker by market capitalisation, posted a 19 percent rise in quarterly profit, slightly above analysts' estimate.
Profit rose to 4.23 billion rupees ($65.21 million)in the second quarter ended Sept. 30, from 3.54 billion rupees a year earlier, the company said. http://bit.ly/2AmueVf
That compares with an average expectation of 4.2 billion rupees in profit, drawn from 18 analysts polled by Thomson Reuters I/B/E/S.
($1 = 64.8700 Indian rupees)
(Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by Sunil Nair)
Disclaimer: No Business Standard Journalist was involved in creation of this content
